Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Taxes (2016 - 2025)

Iradimed (IRMD) has disclosed Current Taxes for 10 consecutive years, with $2.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Taxes changed N/A to $2.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.8 million, a N/A change, with the full-year FY2023 number at $250041.0, changed N/A from a year prior.
  • Current Taxes was $2.8 million for Q3 2025 at Iradimed, up from $583408.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $2.8 million in Q3 2025 to a low of $250041.0 in Q4 2023.
  • A 3-year average of $1.0 million and a median of $583408.0 in 2025 define the central range for Current Taxes.
  • Peak YoY movement for Current Taxes: surged 88.14% in 2024, then plummeted 37.15% in 2025.
  • Iradimed's Current Taxes stood at $250041.0 in 2023, then soared by 271.25% to $928287.0 in 2024, then surged by 201.74% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Current Taxes are $2.8 million (Q3 2025), $583408.0 (Q1 2025), and $928287.0 (Q1 2024).